全文获取类型
收费全文 | 128069篇 |
免费 | 13470篇 |
国内免费 | 8494篇 |
专业分类
耳鼻咽喉 | 1086篇 |
儿科学 | 2188篇 |
妇产科学 | 1532篇 |
基础医学 | 12355篇 |
口腔科学 | 2294篇 |
临床医学 | 17797篇 |
内科学 | 15868篇 |
皮肤病学 | 1373篇 |
神经病学 | 5286篇 |
特种医学 | 4299篇 |
外国民族医学 | 36篇 |
外科学 | 10135篇 |
综合类 | 26734篇 |
现状与发展 | 36篇 |
一般理论 | 10篇 |
预防医学 | 11800篇 |
眼科学 | 3200篇 |
药学 | 14877篇 |
183篇 | |
中国医学 | 10029篇 |
肿瘤学 | 8915篇 |
出版年
2024年 | 531篇 |
2023年 | 1949篇 |
2022年 | 4995篇 |
2021年 | 6307篇 |
2020年 | 5080篇 |
2019年 | 3914篇 |
2018年 | 4065篇 |
2017年 | 4264篇 |
2016年 | 3791篇 |
2015年 | 5768篇 |
2014年 | 7319篇 |
2013年 | 7493篇 |
2012年 | 10672篇 |
2011年 | 11374篇 |
2010年 | 8252篇 |
2009年 | 6969篇 |
2008年 | 8016篇 |
2007年 | 7847篇 |
2006年 | 7242篇 |
2005年 | 6144篇 |
2004年 | 4559篇 |
2003年 | 4332篇 |
2002年 | 3630篇 |
2001年 | 2919篇 |
2000年 | 2416篇 |
1999年 | 2121篇 |
1998年 | 1278篇 |
1997年 | 1206篇 |
1996年 | 964篇 |
1995年 | 840篇 |
1994年 | 778篇 |
1993年 | 417篇 |
1992年 | 454篇 |
1991年 | 392篇 |
1990年 | 366篇 |
1989年 | 296篇 |
1988年 | 280篇 |
1987年 | 227篇 |
1986年 | 185篇 |
1985年 | 122篇 |
1984年 | 94篇 |
1983年 | 38篇 |
1982年 | 27篇 |
1981年 | 29篇 |
1980年 | 19篇 |
1979年 | 10篇 |
1977年 | 6篇 |
1972年 | 6篇 |
1971年 | 6篇 |
1969年 | 5篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
61.
肠易激综合征(Irritable bowel syndrome,IBS)是临床常见病、多发病,其治疗方法丰富,但部分患者疗效欠佳,发展成难治性IBS。目前国内外关于针灸治疗难治性IBS的临床随机对照试验尚不多见。本文立足试验方案设计的“PICOS”原则,从研究对象及诊断标准、干预措施、对照措施、结局指标四个方面入手,重点探讨针刺辅助治疗难治性肠易激综合征临床试验设计的关键要点。从选择特色优势病种、明确诊断标准、制定符合临床实际的干预方案、运用符合目标的安慰针刺、结合研究设计和目的选定结局指标几个角度,阐述试验相关环节设计的原因和思考。 相似文献
62.
63.
64.
65.
66.
Sequential Therapy Based on Evolvement of Patterns: A New Model for Treatment of Alzheimer’s Disease
In order to solve the problem of long-term (>9 months) efficacy in the treatment of Alzheimer''s disease (AD) by conventional therapy (CT), a staged and multiply-targeted sequential therapy based on the evolvement of patterns (STEP) was developed. Its main innovations include: (1) the time order of evolution of patterns defined by Chinese medicine (CM) in AD was found, that is, "the orderly pattern evolution starting from Shen (Kidney) deficiency, progressing to phlegm, stasis and fire, and worsening to severe toxin as well as functional collapse"; (2) the cascade hypothesis of Shen deficiency in AD and its sequential therapy based on Shen-reinforcing was proposed, that is, "reinforcing Shen in the early stage and throughout the whole process, resolving phlegm, activating blood and purging fire in the middle stage, detoxifying and replenishing vitality to stop the collapse in the advanced stage", and through meta-analysis, clinical drug use was optimized, thus the leap from "inferential selection" to "evidence-based selection" was realized; (3) the STEP regimen combined with CT maintained cognitive and behavioral stability in AD patients for at least 12 months, with cognitive enhancement and behavioral synergy after 9 months, and cognitive benefit was superior to CT at 9, 12, 15, 18, 21, and 24 months, respectively. The 2-year cognitive improvement rate was increased by 25.64% (P=0.020) and the cognitive deterioration rate was decreased by 48.71% (P=0.000). Among them, the cognitive and functional benefits of Shen-reinforcing therapy for very early AD (350 cases) for 1 year were better than the placebo (P<0.001), and the dementia conversion rate was reduced by 8.85% (P=0.002). The behavioral symptomatic relief of patients with vascular dementia received fire-purging therapy (540 cases) was superior to those received CT (P=0.016). These data suggested that the STEP regimen has synergistic effects on CTs at least in terms of cognitive benefit, and the earlier the use, the greater the benefit will have. Therefore, the STEP regimen should be considered as one of the clinical options, particularly for the dearth of effective pharmaceutical or immunological interventions that are currently available for AD. 相似文献
67.
68.
69.
70.